Drug dis

Pharmacometric model informed drug development in infectious diseases

  • Chair(s):

    Joe Standing
    Professor of Pharmacometrics,University College London, London, United Kingdom

  • Session description:

    Sponsored by the ISoP Clinical Special Interest Group

    Role of pharmacometric modelling in drug development for infectious diseases
    Dr Patrick Smith
    Certara Ltd
    Leveraging viral dynamic models in antiviral development

    Prof. France Mentre
    Professor of Pharmacometrics and Biostatistics, INSERM, Paris, France

    Oral communication speaker - to be confirmed in 2022.

    Beating malaria with pharmacometrics
    Dr Jeff Barrett
    Bill & Melinda Gates Medical Research Institute, The United States of America,

    Pharmacometrics of antiviral dynamics in SARS-CoV-2
    Dr Silke Gastine
    University College London United Kingdom, London, United Kingdom

  • Sponsored by:

    the British Journal of Clinical Pharmacology


Leave A Comment

Go to Top